Form D Explorer

Form C/A — Barricade Therapeutics Corp.

0002090859-26-000006 · filed 2026-04-20 · via StartEngine Primary, LLC

Offering

Target: $20,000
Maximum: $1,235,000
Security type: Other
Price per security: —
Deadline: —
Oversubscription: Accepted

Issuer

Name: Barricade Therapeutics Corp.
CIK: 2090859
Entity: Corporation
Jurisdiction: DE
Address: 1120 South Freeway, Suite 103
Fort Worth, TX 76104
Phone: —

Most recent fiscal year financials

Total assets

$507,849

Cash

—

Short-term debt

$863,301

Long-term debt

$3,402,669

Revenues

$810,102

COGS

—

Taxes paid

—

Net income

$-436,817

View original on SEC EDGAR.